#455: Is animal testing in drug development on its way out?

<p>In this episode of The Healthtech Podcast, James is joined by Steve Bulera, Chief Scientific Officer for Safety Assessment and Toxicology at Charles River Laboratories — one of the world's largest CROs, and a company that almost every new drug passes through on its way from lab to human trials. They dig into one of the most significant shifts in preclinical drug development: the move away from traditional animal testing towards virtual control groups, AI-assisted decision-making, and what Steve calls "new approach methodologies." It's a candid conversation about where the science is, why the regulators are cautious, and what it actually takes to change a decades-old industry from within.</p><p><br /></p><p>Connect with Steve: <a href="https://www.linkedin.com/in/steven-bulera-245234a9/" rel="ugc noopener noreferrer" target="_blank">https://www.linkedin.com/in/steven-bulera-245234a9/</a> </p><p>Learn more about Charles River Laboratories: <a href="https://www.criver.com" rel="ugc noopener noreferrer" target="_blank">https://www.criver.com</a></p><p><br /></p><p>Apply to be a guest: www.thehealthtechpodcast.com</p><p>Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com</p><p>Get in touch with James: www.jamessomauroo.com</p><p><br /></p><p>This podcast was brought to you by SomX.</p><p><br /></p>